1. Home
  2. DFNS vs RGNT Comparison

DFNS vs RGNT Comparison

Compare DFNS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$0.17

Market Cap

27.2M

ML Signal

N/A

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.90

Market Cap

24.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFNS
RGNT
Founded
2013
2004
Country
United States
Israel
Employees
15
8
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
24.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DFNS
RGNT
Price
$0.17
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.7M
13.7M
Earning Date
04-09-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.23
52 Week High
$2.68
$15.50

Technical Indicators

Market Signals
Indicator
DFNS
RGNT
Relative Strength Index (RSI) 28.42 53.12
Support Level N/A $1.95
Resistance Level $0.51 $7.80
Average True Range (ATR) 0.03 2.17
MACD 0.00 0.05
Stochastic Oscillator 6.06 18.79

Price Performance

Historical Comparison
DFNS
RGNT

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: